Pharmacyclics buy melinda
Start price
01.12.11
/
50%
€11.50
Target price
07.12.11
€11.00
Performance (%)
0.00%
End price
07.12.11
€11.50
Summary
This prediction ended on 07.12.11 with a price of €11.50. The BUY prediction by melinda closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pharmacyclics | - | - | - | - |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % | 59,64 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % | 82,45 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % | 59,33 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % | 55,65 % |
Comments by melinda for this prediction
In the thread Pharmacyclics diskutieren
Krebsbehandlung
Pharmacyclics Inc. ist ein Entwickler von Medikamenten war kleiner Moleküle zur Behandlung von Krebs
(Vom Mitglied beendet)


